Study on Prediction of Acute Exacerbation of COPD and Screening of Disease Markers Based on Machine Learning
RESEARCH PAPER|更新时间:2023-08-03
|
Study on Prediction of Acute Exacerbation of COPD and Screening of Disease Markers Based on Machine Learning
New Generation of Information TechnologyVol. 5, Issue 24, Pages: 12-17(2022)
作者机构:
1.牡丹江医学院,黑龙江 牡丹江 157011
2.牡丹江医学院附属红旗医院,黑龙江 牡丹江 157011
作者简介:
基金信息:
Basic Scientific Research Business Cost Project of Colleges And Universities in Heilongjiang Province(2020-KYYWFMY-0052);Mudanjiang Medical College Postgraduate Tutor Scientific Research Project(YJSZX2022135)
YU Miao, GUO Jin-xing, SUN Yue, et al. Study on Prediction of Acute Exacerbation of COPD and Screening of Disease Markers Based on Machine Learning[J]. New Generation of Information Technology, 2022, 5(24): 12-17
YU Miao, GUO Jin-xing, SUN Yue, et al. Study on Prediction of Acute Exacerbation of COPD and Screening of Disease Markers Based on Machine Learning[J]. New Generation of Information Technology, 2022, 5(24): 12-17 DOI: 10.3969/j.issn.2096-6091.2022.24.003.
Study on Prediction of Acute Exacerbation of COPD and Screening of Disease Markers Based on Machine Learning
In response to the difficulties and poor accuracy of clinical diagnosis for patients with acute exacerbation of chronic obstructive pulmonary disease, we propose to construct a clinical prediction model based on machine learning and use SHAP model interpretability to screen key disease features. By comparing the predictive performance and feature importance of different machine learning models and conducting model interpretability analysis, we aim to find the optimal model and disease marker features. We selected a dataset of 99 patients with COPD from the University College London patient database. We used six machine learning algorithms to establish a prediction model and evaluated the model using k-fold cross-validation and evaluation metrics such as ROC-AUC and f1 score. We then used SHAP for interpretability analysis of the prediction model. Among all the models, the SVC model had the best predictive performance, with an accuracy of 0.93 and AUC of 0.99. FEV1PRED and FEV1 were identified as important factors affecting COPDSEVERITY. The machine learning prediction model can provide effective decision-making support for the diagnosis of COPDSEVERITY.
FERNANDEZ-GRANERO M A, SANCHEZ-MORILLOD D, LEON-JIMENEZ A. An artificial intelligence approach to early predict symptom-based exacerbations of COPD[J]. Biotechnology & Biotechnological Equipment, 2018, 32(3): 778-784.
MOHKTAR M S, REDMOND S J, ANTONIADES N C, et al. Predicting the risk of exacerbation in patients with chronic obstructive pulmonary disease using home telehealth measurement data[J]. Artificial Intelligence in Medicine, 2015, 63(1): 51-59.
SHAH S A, VELARDO C, FARMER A, et al. Exacerbations in chronic obstructive pulmonary disease: Identification and prediction using a digital health system[J]. Journal of Medical Internet Research, 2017, 19(3): e69.
VERMA V K, LIN W Y. A machine learning-based predictive model for 30-day hospital readmission prediction for COPD patients[C]//2020 IEEE International Conference on Systems, Man, and Cybernetics (SMC). Piscataway: IEEE, 2020: 994-999.
PAN W H, CHEN J Y, HAUNG S L, et al. Reference spirometric values in healthy Chinese neversmokers in two townships of Taiwan, China[J]. The Chinese Journal of Physiology, 1997, 40(3): 165-174.
IP M S, WAI-SAN KO F, LAU A C, et al. Updated spirometric reference values for adult Chinese in Hong Kong, China and implications on clinical utilization[J]. Chest, 2006, 129(2): 384-392.
DUONG M, ISLAM S, RANGARAJAN S, et al. Global differences in lung function by region (PURE): An International, community-based prospective study[J]. Lancet Respiratory Medicine, 2013, 1(8): 599-609.
MCKEON F, XIAN W, RAO W, et al. Regenerative metaplastic clones in COPD lung drive inflammation and fibrosis[J]. Cell, 2020, 181(4): 848-864.
JIA T G, ZHAO J Q, LIU J H. Serum inflammatory factor and cytokines in AECOPD [J]. Asian Pacific Journal of Tropical Medicine, 2014, 7(12): 1005-1008.
KARADENIZ G, POLAT G, SENOL G, et al. C-reactive protein measurements as a marker of the severity of chronic obstructive pulmonary disease exacerbations[J]. Inflammation, 2013, 36(4): 948-953.
PIKOULA M, QUINT J K, NISSEN F, et al. Identifying clinically important COPD sub-types using data-driven approaches in primary care population based electronic health records[J]. Medical Informatics and Decision Making, 2019, 19(1): 86.
WANG C, CHEN X, DU L, et al. Comparison of machine learning algorithms for the identification of acute exacerbations in chronic obstructive pulmonary disease[J]. Computer Methods and Programs in Biomedicine, 2020, 188: 105267.
CHEN J, YANG Z, YUAN Q, et al. Prediction models for pulmonary function during acute exacerbation of chronic obstructive pulmonary disease[J]. Physiological Measurement, 2021, 41(12): 125010.